A61K 31/527
Spiro-condensed
Official title: spiro-condensed
A61K31/527 (Spiro-condensed) appears on 96 US grants and 167 published applications in this corpus.
Search patents in A61K- Granted patents
- 96
- Published applications
- 167
- Assignees
- 76
- Inventors
- 353
- Latest grant
- 12 May 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1998 | 1 | 0 |
| 1999 | 1 | 0 |
| 2000 | 1 | 0 |
| 2001 | 1 | 0 |
| 2002 | 1 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 1 |
| 2006 | 0 | 1 |
| 2007 | 1 | 1 |
| 2008 | 0 | 3 |
| 2009 | 2 | 2 |
| 2010 | 1 | 4 |
| 2011 | 1 | 3 |
| 2012 | 0 | 1 |
| 2013 | 2 | 7 |
| 2014 | 9 | 14 |
| 2015 | 9 | 21 |
| 2016 | 15 | 10 |
| 2017 | 6 | 13 |
| 2018 | 7 | 15 |
| 2019 | 11 | 13 |
| 2020 | 6 | 6 |
| 2021 | 9 | 8 |
| 2022 | 3 | 4 |
| 2023 | 3 | 11 |
| 2024 | 2 | 5 |
| 2025 | 2 | 12 |
| 2026 | 2 | 12 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- High-activity Wnt pathway inhibitor compound12 May 2026US 12,622,917 B2Adlai Nortye Biopharma Co., Ltd.
- Uracil derivatives having virus replication inhibitory activity and pharmaceutical composition comprising the same10 Feb 2026US 12,545,687 B2Shionogi & Co., Ltd.
- 1,4-dihydroquinazolinone compounds and uses thereof30 Dec 2025US 12,509,431 B2Edgewise Therapeutics, Inc.
- Methods of treating elevated plasma cholesterol23 Sep 2025US 12,419,888 B2Affina Biotechnologies, Inc.
- Engaging the cervical spinal cord circuitry to re-enable volitional control of hand function in tetraplegic subjects3 Sep 2024US 12,076,301 B2The Regents of the University of California
- Spirocyclic dihydropyranopyrimidine kras inhibitors10 Sep 2026US 2026/0265264 A1Treeline Biosciences, Inc.
- Heterocyclic compounds as wrn inhibitors27 Aug 2026US 2026/0250286 A1Synnovation Therapeutics, Inc.
- Amino-imidazole antibacterial compounds18 Jun 2026US 2026/0167657 A1Hoffmann-La Roche Inc.
- Uracil derivatives having virus replication inhibitory activity and pharmaceutical composition comprising the same7 May 2026US 2026/0125392 A1Shionogi & Co., Ltd.
- Cyclic urea thiazolyl compounds for treatment of hsv16 Apr 2026US 2026/0103471 A1Assembly Biosciences, Inc.
Most cited
By later US patents
- CDK inhibitors46US 8,691,830 B2G1 Therapeutics, Inc. · 2014
- CDK inhibitors44US 8,822,683 B2G1 Therapeutics, Inc. · 2014
- CDK inhibitors44US 8,829,012 B2G1 Therapeutics, Inc. · 2014
- Methods and compositions for treating Raynaud's Phenomenon and scleroderma37US 6,444,681 B1The Ohio State University Research Foundation · 2002
- Modulators of toll-like receptors35US 8,367,670 B2Gilead Sciences, Inc. · 2013